Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

The ERSPC (European Randomized Study of Screening for Prostate Cancer) found that screening reduced prostate cancer mortality, but the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found no reduction. To evaluate whether effects of screening on prostate cancer mortality relat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of internal medicine Jg. 167; H. 7; S. 449
Hauptverfasser:	Tsodikov, Alex, Gulati, Roman, Heijnsdijk, Eveline A M, Pinsky, Paul F, Moss, Sue M, Qiu, Sheng, de Carvalho, Tiago M, Hugosson, Jonas, Berg, Christine D, Auvinen, Anssi, Andriole, Gerald L, Roobol, Monique J, Crawford, E David, Nelen, Vera, Kwiatkowski, Maciej, Zappa, Marco, Luján, Marcos, Villers, Arnauld, Feuer, Eric J, de Koning, Harry J, Mariotto, Angela B, Etzioni, Ruth
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 03.10.2017
Schlagworte:	Aged Early Detection of Cancer - statistics & numerical data Europe - epidemiology Humans Incidence Male Mass Screening - statistics & numerical data Middle Aged Proportional Hazards Models Prostatic Neoplasms - diagnosis Prostatic Neoplasms - epidemiology Prostatic Neoplasms - mortality Randomized Controlled Trials as Topic Time Factors United States - epidemiology
ISSN:	1539-3704, 1539-3704
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!